跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BORTEZOMIB FOR INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BORTEZOMIB FOR INJECTION
Authorized
STANDARD
BORTEZOMIB FOR INJECTION
Juno Pharmaceuticals Corp.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
0e019c52fc55714f
Company
Juno Pharmaceuticals Corp.
Type
Standard
Approval Details
Approval Id
0e019c52fc55714f
Drug Approval Canada Name
BORTEZOMIB FOR INJECTION
Product Name
BORTEZOMIB FOR INJECTION
Status
Marketed
Status Date
2023-03-28
Original Market Date
2023-03-28
Din
02485257
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Subcutaneous , Intravenous
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01XG01 BORTEZOMIB
Atc Name
l 01 xg 01
Aig Number
0150433001
Company Name
Juno Pharmaceuticals Corp.
Company Address
402, 2233 Argentia Road, Mississauga, Ontario, Canada, L5N 2X7
Active Ingredients
BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER)
3.5 MG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
0e019c52fc55714f
Type
Standard
Back to Health Canada Approvals